Decision Intelligence in Glaucoma Care

Integrating advanced analytics with clinical data can improve management decisions and patient outcomes.

By: Lama A. Al-Aswad, MD, MPH, Almiqdad Saeed, MD

Glaucoma Physician March 1, 2026 Page(s): 6-8

Clinical Report: Decision Intelligence in Glaucoma Care

Overview

Enhance by specifying how decision intelligence addresses data fragmentation and complexity.

Background

Glaucoma remains a leading cause of preventable vision loss, often diagnosed late due to its asymptomatic nature in early stages. The complexity of managing glaucoma is compounded by the need for continuous monitoring and individualized treatment strategies that consider a patient's unique circumstances. Decision intelligence offers a framework to synthesize diverse clinical data, facilitating timely and informed decision-making.

Data Highlights

No specific numerical data provided in the article.

Key Findings

Decision intelligence combines data analytics, artificial intelligence, and decision science to enhance clinical judgment in glaucoma care.
Fragmentation of clinical data across various platforms complicates timely decision-making and patient management.
Patient-centered care emphasizes individualized risk assessment and shared decision-making, which is crucial in glaucoma management.
Current guidelines advocate for structured, risk-stratified care and the integration of patient preferences into treatment plans.
Longitudinal data is essential for confirming disease presence and progression, highlighting the need for comprehensive monitoring.

Clinical Implications

Clinicians should leverage decision intelligence tools to integrate diverse data sources, enhancing the accuracy of glaucoma management decisions. Emphasizing patient-centered care can improve adherence and treatment outcomes by aligning management strategies with individual patient goals.

Conclusion

Reiterate the impact of decision intelligence on vision loss reduction and patient care.

PentaVision

Glaucoma Physician